Premier Path Wealth Partners, LLC Gilead Sciences, Inc. Transaction History
Premier Path Wealth Partners, LLC
- $531 Billion
- Q1 2024
A detailed history of Premier Path Wealth Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 3,927 shares of GILD stock, worth $284,943. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,927
Previous 4,922
20.22%
Holding current value
$284,943
Previous $399 Million
27.86%
% of portfolio
0.05%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
1,892Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.89 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$8.32 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$6.13 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.44 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$4.19 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $90.9B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...